Teledyne Technologies R&D increased by 9.6% to $84.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.9%, from $74.30M to $84.60M. Over 3 years (FY 2022 to FY 2025), R&D shows relatively stable performance with a -3.4% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $88.05M | $88.05M | $88.05M | $88.05M | $89.08M | $89.08M | $89.08M | $89.08M | $76.50M | $71.70M | $73.00M | $71.40M | $74.30M | $82.40M | $83.40M | $77.20M | $84.60M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +1.2% | +0.0% | +0.0% | +0.0% | -14.1% | -6.3% | +1.8% | -2.2% | +4.1% | +10.9% | +1.2% | -7.4% | +9.6% |
| YoY Change | — | — | — | — | +1.2% | +1.2% | +1.2% | +1.2% | -14.1% | -19.5% | -18.0% | -19.8% | -2.9% | +14.9% | +14.2% | +8.1% | +13.9% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Digital Imaging | $44.10M | $48.20M | $50.70M | $44.50M | $52.40M |
| Instrumentation | $24.20M | $25.70M | $24.40M | $25.10M | $25.10M |
| Aerospace and Defense Electronics | $6.00M | $8.20M | $8.20M | $7.40M | $6.90M |
| Engineered Systems | $0.00 | $300.00K | $100.00K | $200.00K | $200.00K |
| Total | $74.30M | $82.40M | $83.40M | $77.20M | $84.60M |